Project Number 3U01AG063768-02S1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease. Research Categorization Primary Disease / Condition Vascular Dementia/Dysfunction Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) k. Vasculature Researcher and Organization Principal Investigator RODGERS, KATHLEEN E. Principal Investigator First Name KATHLEEN Principal Investigator Last Name RODGERS Awardee Organization UNIVERSITY OF ARIZONA Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $383,750 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
